CLINICAL_TRIALS
trial_result
· 2008-09-29
Clinical Trial Update: Chemoprevention of Oral Premalignant Lesions [Phase 2]
Summary
Pfizer-sponsored Phase 2 trial evaluating chemoprevention of oral premalignant lesions has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Pfizer | Conditions: Precancerous Conditions | Phase 2 | Status: COMPLETED